NICHOLAS PUGLIELLI: Open Payments
NPI 1144930363 · BEAVER FALLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,176 in 97 payments from 17 companies in 2025. Trend: 2023 $803 · 2024 $1,242 · 2025 $2,176
Food & beverage: $2,176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $475 |
| Madrigal Pharmaceuticals | 11 | $382 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $197 |
| Ardelyx, Inc. | 9 | $179 |
| Regeneron Healthcare Solutions, Inc. | 6 | $174 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $171 |
| PFIZER INC. | 5 | $102 |
| Celltrion USA Inc. | 4 | $93 |
| Phathom Pharmaceuticals, Inc. | 6 | $91 |
| Janssen Biotech, Inc. | 3 | $88 |
Products named: REZDIFFRA, SKYRIZI, IBSRELA, DUPIXENT, RINVOQ, XIFAXAN, EOHILIA, VEGZELMA.
Industry payments across PA — which companies pay providers there.
